Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS

Annual Review of Medicine

Volumn 50, Issue , 1999, Pages 425-440

  Locati, Massimo ^a   Murphy, Philip M ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

AIDS; CCR5; HIV; Inflammation; Leukocyte; Malaria

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; HEMATOPOIESIS; HUMAN; INFLAMMATION; ORGANOGENESIS; PRIORITY JOURNAL; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; EMBRYONIC AND FETAL DEVELOPMENT; GTP-BINDING PROTEINS; HEMATOPOIESIS; HIV-1; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CHEMOKINE;

EID: 0033051750     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.50.1.425     Document Type: Review

References (81)

1. 1. Wolpe SD, Cerami A. 1989. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J. 3:2565-73
2. 2. Baggiolini M, Dewald B, Moser B. 1994. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55:97-179
3. 3. Vaddi K, Keller M, Newton RC. 1997. The Chemokine Facts Book. San Diego: Academic
4. 4. Luster AD. 1998. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-45
5. 5. Yoshimura T, Matsushima K, Tanaka S, et al. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84:9233-37
6. 6. Koch AE, Polverini PJ, Kunkel SL, et al. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-801
7. 7. Strieter RM, Polverini PJ, Arenberg DA, et al. 1995. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J. Leukoc. Biol. 57:752-62
8. 8. Broxmeyer HE, Mantel CR, Aronica SM. 1997. Biology and mechanisms of action of synergistically stimulated myeloid progenitor cell proliferation and suppression by chemokines. Stem Cells 15(Suppl 1): 69-77
9. 9. Nagasawa T, Hirota S, Tachibana K, et al. 1996. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/ SDF-1. Nature 382:635-38
10. 9a.Zou YR, Kottmann AH, Kuroda M, et al. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595-99
11. 9b. Tachibana K, Hirota S, Iizasa H, et al. 1998. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393:591-94
12. 10. Cocchi F, DeVico AL, Garzino-Demo A, et al. 1995. Identification of RANTES, MIP-1a, and MIP-1b as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-15
13. 11. Feng Y, Broder CC, Kennedy PE, Berger E. 1996. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane G-protein coupled receptor. Science 272:872-77
14. 12. Berger EA. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS 11(Suppl. A):S3-16
15. 13. Rucker J, Edinger AL, Sharron M, et al. 1997. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 71:8999-9007
16. 14. Pease JE, Murphy PM. 1998. Microbial corruption of the chemokine system: an expanding paradigm. Semin. Immunol. 10:169-78
17. 15. Kelner GS, Kennedy J, Bacon KB, et al. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395-98
18. 3C motif. Nature 385:640-44
19. 17. Murphy PM. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593-633
20. 18. Murphy PM. 1996. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7:47-64
21. 19. Yoshie O, Imai T, Nomiyama H. 1997. Novel lymphocyte-specific CC chemokines and their receptors. J. Leukoc. Biol. 62:634-44
22. 3CR1, which mediates both leukocyte migration and adhesion. Cell 91:521-30
23. 21. Hedrick JA, Helms A, Vicari A, Zlotnik A. 1998. Characterization of a novel CC chemokine, HCC-4, whose expression is increased by interleukin-10. Blood 91: 4242-47
24. 22. Gunn MD, Ngo VN, Ansel KM, et al. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799-803
25. 23. Bonecchi R, Bianchi G, Bordignon PP, et al. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187: 129-34
26. 24. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875-83
27. 25. Murphy PM. 1997. Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin. Hematol. 34:311-18
28. 26. Foxman EF, Campbell JJ, Butcher EC. 1997. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 139:1349-60
29. 27. Loetscher M, Gerber B, Loetscher P, et al. 1996. Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:963-70
30. 28. Springer TA. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-14
31. 29. Middleton J, Neil S, Wintle J, et al. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91:385-95
32. 30. Lira SA. 1996. Genetic approaches to study chemokine function. J. Leukoc. Biol. 59:45-52
33. 31. Cacalano G, Lee J, Kikly K, et al. 1994. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265:682-85
34. 32. Forster R, Mattis AE, Kremmer E, et al. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87: 1037-47
35. 33. Rothenberg ME, MacLean JA, Pearlman E, et al. 1997. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:785-90
36. 34. Furie MB, Randolph GJ. 1995. Chemokines and tissue injury. Am. J. Pathol. 146: 1287-301
37. 35. Harada A, Sekido N, Akahoshi T, et al. 1994. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol. 56:559-64
38. 36. Ransohoff RM, Glabinski A, Tani M. 1996. Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev. 7: 35-46
39. 37. Karpus WJ, Lukacs NW, McRae BL, et al. 1995. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:5003-10
40. 38. Cook DN, Beck MA, Coffman TM, et al. 1995. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583-85
41. 39. Lu B, Rutledge BJ, Gu L, et al. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187:601-8
42. 40. Boring L, Gosling J, Chensue SW, et al. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100:2552-61
43. 41. Kurihara T, Warr G, Loy J, Bravo R. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186:1757-62
44. 41a. Boring L, Gosling J, Cleary M, Charo IF. 1998. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-97
45. 42. Luster AD, Rothenberg ME. 1997. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J. Leukoc. Biol. 62:620-33
46. 43. Heath H, Qin S, Rao P, et al. 1997. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:178-84
47. 44. Gerber BO, Zanni MP, Uguccioni M, et al. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 7:836-43
48. 45. Gao JL, Wynn TA, Chang Y, et al. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1959-68
49. 46. Chensue SW, Warmington KS, Ruth JH, et al. 1996. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J. Immunol. 157:4602-8
50. 47. Gerard C, Frossard JL, Bhatia M, et al. 1997. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J. Clin. Invest. 100:2022-27
51. 48. Zhou Y, Kurihara T, Ryseck RP, et al. 1998. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160:4018-25
52. 49. Gengrinovitch S, Greenberg SM, Cohen T, et al. 1995. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms. J. Biol. Chem. 270:15059-65
53. 50. Horuk R, Chitnis C, Darbonne W, et al. 1993. The erythrocyte chemokine receptor is a receptor for the malarial parasite Plasmodium vivax. Science 261:1182-84
54. 51. Horuk R. 1994. The interleukin-8-receptor family: from chemokines to malaria. Immunol. Today 15:169-74
55. 52. Gao J-L, Murphy PM. 1994. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J. Biol. Chem. 269:28539-42
56. 53. Ahuja SK, Murphy PM. 1993. Molecular piracy of mammalian interleukin-8 receptor type B by Herpesvirus saimiri. J. Biol. Chem. 268:20691-94
57. 54. Arvanitakis L, Geras-Raaka E, Varma A, et al. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347-50
58. 55. Kledal TN, Rosenkilde MM, Coulin F, et al. 1997. A broad-spectrum chemokine antagonist encoded by Kaposi's Sarcoma-Associated Herpesvirus. Science 277:1656-59
59. 56. Damon I, Murphy PM, Moss B. 1998. Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc. Natl. Acad. Sci. USA 95: 6403-7
60. 57. Smith CA, Smith TD, Smolak PJ, et al. 1997. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236:316-27
61. 58. Sattentau QJ, Weiss RA. 1988. The CD4 antigen: physiological ligand and HIV receptor. Cell 52:631-33
62. 59. Schuitemaker H, Koot M, Kootstra NA, et al. 1992. Biological phenotype of human immunmodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from a monocytotropic to T-cell tropic virus populations. J. Virol. 66:1354-60
63. 60. Simmons G, Wilkinson D, Reeves JD, et al. 1996. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:8355-60
64. 61. Pleskoff O, Treboute C, Brelot A, et al. 1997. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276:1874-78
65. 62. He J, Chen Y, Farzan M, et al. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645-49
66. 63. Baggiolini M, Moser B. 1997. Blocking chemokine receptors. J. Exp. Med. 186: 1189-91
67. 64. Liu R, Paxton WA, Choe S, et al. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-77
68. 65. Dean M, Carrington M, Winkler C, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-62
69. 66. Zimmerman PA. Genetic resistance to HIV-1 infection. In Chemokines, ed. C Hebert. Totowa, NJ: Humana. In press
70. 67. Wu L, Paxton WA, Kassam N, et al. 1997. CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1, in vitro. J. Exp. Med. 185: 1681-91
71. 68. Benkirane M, Jin DY, Chun RF, et al. 1997. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J. Biol Chem. 272: 30603-6
72. 69. Quillent C, Oberlin E, Braun J, et al. 1998. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 351:14-18
73. 70. Smith MW, Dean M, Carrington M, et al. 1997. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277:959-65
74. 71. Winkler C, Modi W, Smith MW, et al. 1998. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 279:389-93
75. 72. McDermott DA, Zimmerman PA, Guignard F, et al. 1998. CCR5 promoter polymorphism affects HIV-1 disease progression. Lancet. In press
76. 73. Zhang L, He T, Talal A, et al. 1998. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J. Virol. 72:5035-45
77. 74. Paxton WA, Martin SR, Tse D, et al. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high risk sexual exposures. Nat. Med. 2: 412-17
78. 75. Margolis LB, Glushakova S, Grivel JC, Murphy PM. 1998. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. J. Clin. Invest. 101:1876-80
79. 76. Tournamille C, Colin Y, Cartron JP, Van Kim C. 1995. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10: 224-28
80. 77. Murphy PM, Horuk R, Charo IF, et al. 1999. International Union of Pharmacology Nomenclature for chemokine receptors. Pharm. Rev. In press
81. 78. Berger EA, Murphy PM, Farber JM. 1999. Chemokine receptors as HIV coreceptors: roles in viral entry, tropism and disease. Annu. Rev. Immunol. 17:In press